RYLENTIX Trademark

Trademark Overview


On Thursday, June 29, 2017, a trademark application was filed for RYLENTIX with the United States Patent and Trademark Office. The USPTO has given the RYLENTIX trademark a serial number of 87510865. The federal status of this trademark filing is REGISTERED as of Tuesday, May 21, 2019. This trademark is owned by Abiogen Pharma S.p.A.. The RYLENTIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronate sodium; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronate sodium
rylentix

General Information


Serial Number87510865
Word MarkRYLENTIX
Filing DateThursday, June 29, 2017
Status700 - REGISTERED
Status DateTuesday, May 21, 2019
Registration Number5754281
Registration DateTuesday, May 21, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 4, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronate sodium; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronate sodium

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 7, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbiogen Pharma S.p.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressOspedaletto, Pisa (PI) 56121
IT

Party NameAbiogen Pharma S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressOspedaletto, Pisa (PI) 56121
IT

Party NameAbiogen Pharma S.p.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressOspedaletto, Pisa (PI) 56121
IT

Trademark Events


Event DateEvent Description
Monday, October 9, 2017SUSPENSION LETTER WRITTEN
Monday, July 3, 2017NEW APPLICATION ENTERED
Friday, July 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 26, 2017ASSIGNED TO EXAMINER
Monday, October 9, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 9, 2017LETTER OF SUSPENSION E-MAILED
Monday, April 9, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, April 9, 2018INQUIRY TO SUSPENSION E-MAILED
Monday, April 9, 2018SUSPENSION INQUIRY WRITTEN
Monday, October 8, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 8, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 17, 2018ASSIGNED TO LIE
Sunday, April 14, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, October 29, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 29, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 29, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 4, 2018PUBLISHED FOR OPPOSITION
Tuesday, December 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 3, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 21, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, May 21, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED